How Each Compound Works in the Body Retatrutide activates GLP-1, GIP, and glucagon receptors to reduce appetite, increase energy expenditure, and improve insulin secretion
Clinical trial data shows diarrhea rates of 19-23% across doses, with nausea remaining the predominant side effect at 24-31%
For a standard 10mg vial of Retatrutide Powder, reconstituting with 2 mL of bacteriostatic water creates a concentration of 5 mg/mL, which is ideal for moderate dosing protocols
This dual mechanism distinguishes tirzepatide from single-action GLP-1 receptor agonists like semaglutide
No offboarding plan Programs without a tapering strategy leave members on medication indefinitely which drives up long-term spend
Just keep in mind that results are not guaranteed